Apotex Inc.
Pradeep Sanghvi is an accomplished executive in the pharmaceutical research and development sector, currently serving as Executive Vice President, Global R&D at Apotex Inc. since October 2021. With a robust background in R&D, Pradeep previously held the role of Executive Vice President, R&D at Sun Pharmaceuticals from April 2016 to October 2021 and returned to Apotex Inc. in a similar capacity from May 2009 to April 2016. Earlier career advancements include Vice President of Pharmaceutical Development at MonoSol Rx, LLC, and Director positions at Penwest Pharmaceuticals and Biovail/Fuisz. Pradeep Sanghvi earned a Ph.D. in Pharmaceutics from Duquesne University, which was completed in 1994.
This person is not in any teams
This person is not in any offices